SKI Market

A+| A| A-|

Indian Indices

Sensex

75,527.95 1,695.40
( 2.30%)

Global Indices

Nasdaq

50,865.93 926.15
(1.85%)

Dow Jones

7,414.60 126.61
(1.74%)

Hang Seng

66,063.56 1,846.29
(2.88%)

Nikkei 225

10,460.24 156.36
(1.52%)

Forex

USD-INR

95.34 -0.07
(-0.08%)

EUR-INR

110.08 -0.10
(-0.09%)

GBP-INR

127.59 -0.01
(-0.01%)

JPY-INR

0.59 0.00
(-0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Caplin Point Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524742

INE475E01026

269.7614245

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CAPLIPOINT

44.68

17716.81

EPS(TTM)

Face Value()

Div & Yield %

52.17

0.17

Back

Praveg consolidated net profit rises 2.09% in the December 2025 quarter

Feb 13,2026

Net profit of Praveg rose 2.09% to Rs 9.28 crore in the quarter ended December 2025 as against Rs 9.09 crore during the previous quarter ended December 2024. Sales rose 66.64% to Rs 90.45 crore in the quarter ended December 2025 as against Rs 54.28 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	90.45	54.28	67
OPM %	29.02	39.55	-
PBDT	23.12	20.14	15
PBT	10.92	13.37	-18
NP	9.28	9.09	2

75,527.95 1,695.40 ( 2.30%)

50,865.93 926.15 (1.85%)

7,414.60 126.61 (1.74%)

66,063.56 1,846.29 (2.88%)

10,460.24 156.36 (1.52%)

95.34 -0.07 (-0.08%)

110.08 -0.10 (-0.09%)

127.59 -0.01 (-0.01%)

0.59 0.00 (-0.20%)